One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

BACKGROUND: Secondary hyperparathyroidism (sHPT), a common complication of chronic kidney disease, is characterized by elevated serum parathyroid hormone (PTH). Etelcalcetide is an intravenous calcimimetic that increases sensitivity of the calcium-sensing receptor to calcium and decreases PTH secret...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nephrol Dial Transplant
Auteurs principaux: Bushinsky, David A, Chertow, Glenn M, Cheng, Sunfa, Deng, Hongjie, Kopyt, Nelson, Martin, Kevin J, Rastogi, Anjay, Ureña-Torres, Pablo, Vervloet, Marc, Block, Geoffrey A
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2019
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7538239/
https://ncbi.nlm.nih.gov/pubmed/30859218
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfz039
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires